SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-22-024301
Filing Date
2022-05-05
Accepted
2022-05-05 17:45:28
Documents
1
Period of Report
2022-04-06

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 4239
  Complete submission text file 0001213900-22-024301.txt   5656
Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address DORFSTRASSE 29 ZUG V8 6300 41 41 510 8022
MoonLake Immunotherapeutics (Issuer) CIK: 0001821586 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CORMORANT ASSET MANAGEMENT, LLP 200 CLARENDON STREET, FL 52 BOSTON MA 02116
Business Address
Phillips Andrew John (Reporting) CIK: 0001921956 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39630 | Film No.: 22897991